NM_018972.4:c.368A>G
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PP3PP5_Very_Strong
The NM_018972.4(GDAP1):c.368A>G(p.His123Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,398 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_018972.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461398Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727070
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease axonal type 2K Pathogenic:2Uncertain:1
- -
- -
- -
not provided Pathogenic:2
- -
The H123R pathogenic variant in the GDAP1 gene has been reported previously in multiple unrelatedfamilies with autosomal dominant Charcot-Marie-Tooth (CMT) disease (Zimon et al., 2011; Auranenet al., 2013; Pezzini et al., 2016) . The H123R variant has been determined to be a founder mutationin the Finnish population and accounts for up to 14% of Finnish individuals with a clinical diagnosis ofCMT2 (Auranen et al., 2013). The H123R variant was not observed in approximately 6500individuals of European and African American ancestry in the NHLBI Exome Sequencing Project,indicating it is not a common benign variant in these populations. This conservative amino acidsubstitution occurs at a position that is conserved in mammals and in silico analysis is inconsistent inits predictions as to whether or not the variant is damaging to the protein structure/function. Missensevariants in nearby residues (R120G, R120W, R120Q, Q122K, D129H) have been reported in theHuman Gene Mutation Database in association with CMT (Stenson et al., 2014), supporting thefunctional importance of this region of the protein. We interpret H123R as a pathogenic variant. -
Charcot-Marie-Tooth disease Uncertain:1Other:1
- -
- -
Charcot-Marie-Tooth disease type 4A Pathogenic:1
This missense change has been observed in individual(s) with autosomal dominant Charcot-Marie-Tooth disease and is associated with reduced penetrance (PMID: 21753178, 23456260, 23963299, 26525999). In at least one individual the variant was observed to be de novo. It is commonly reported in individuals of Finnish ancestry (PMID: 21753178, 23456260, 23963299, 26525999). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces histidine, which is basic and polar, with arginine, which is basic and polar, at codon 123 of the GDAP1 protein (p.His123Arg). ClinVar contains an entry for this variant (Variation ID: 50558). For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects GDAP1 function (PMID: 28220846). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at